OCUWELL, an innovative medical technology company focused on advancing ocular health solutions, has announced the successful completion of a second £125,000 investment tranche from LYVA Labs through its Liverpool City Region Combined Authority-backed challenge fund. This latest funding brings LYVA Labs’ total investment in OCUWELL to £250,000 and forms part of the company’s £700,000 seed funding round.
The continued support from LYVA Labs reflects strong confidence in OCUWELL's vision, progress, and potential to deliver impactful solutions within the medical and engineering space. The investment will enable OCUWELL to further accelerate product development, strengthen its research and development capabilities, and advance key milestones as the company moves towards commercialisation.
OCUWELL is a medical technology company focused on developing innovative solutions to improve ocular health and patient outcomes through engineering-led approaches.